MeSH tree: D09.408.051.059
Stopping a cancer cell from dividing does not necessarily make it harmless. Chemotherapy can leave behind living, senescent cells. These 'zombie' cells can release inflammatory signals, helping tumors resist treatment. Drugs ...
The chemotherapy agent doxorubicin is used successfully to treat a range of cancers but can, as a side effect, damage the heart muscle. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have now identified ...
Sep 21, 2026
0
7
Stopping tumor growth is only half the battle. Rather than killing tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells ...
Aug 20, 2026
0
12
A new study reveals that the cardioprotective drug dexrazoxane significantly reduces heart damage caused by chemotherapy in pediatric cancer patients 15 years or more after treatment ends.
Aug 7, 2026
0
10
A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular ...
Jul 29, 2026
0
3
Scientists in Britain and Spain have discovered critical windows after glioblastoma surgery when the brain's defenses falter, creating a rare chance to deliver powerful treatments exactly where needed. If doctors time treatment ...
Jul 29, 2026
0
8
An increasing number of Americans are getting—and surviving—cancer. There were more than 18 million cancer survivors in the U.S. in 2025, and the National Cancer Institute estimates that number will grow to 22 million by ...
Jun 18, 2026
0
6
Researchers in the lab of Cancer Center at Illinois (CCIL) member Xing Wang have discovered the influential role of structural chirality, or "handedness," of a DNA nanostructure to dictate cancer cell response to targeted ...
Jun 8, 2026
0
9
An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests on human-derived tumors in mice. Triple-negative breast cancer lacks three common drug targets, ...
Apr 22, 2026
0
5
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy ...
Mar 25, 2026
0
6
